sftd
Cervarix®, Cervical Cancer Vaccine of Long Effectivity
Filed in archive Studies , Treatment by Gloria Gamat on April 12, 2006
Cervarix®, Cervical Cancer Vaccine of Long Effectivity
Cervical cancer is the second most malignant cancer in women caused by Human Papilloma Virus (HPV) that is spread through sexual contact.

GlaxoSmithKline's Cervarix® is an experimental vaccine against cervical cancer. A study conducted by a research team from Dartmouth Medical School, USA claims that Cervarix® can protect women against cervical cancer for at least four and a half years and may also provide protection form other viruses that cause cancer.

The report on this study headed by Dr. Diane Harper can be read at the April 6 issue of The Lancet.

Source: Medical News Today

Permalink: Cervarix®, Cervical Cancer Vaccine of Long Effectivity
Tags: cervical  cancer 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/19939
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Cervarix®, Cervical Cancer Vaccine of Long Effectivity:

  • Currently 8.14/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.14 out of 7 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!